This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Vaccinia Virus A14 Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for vaccinia virus protein A14. It is affinity purified by protein A. It can be applied to IP, WB and IF assays of vaccinia virus protein A14.
Specifications
Target Information
The vaccinia virus protein A14, also known as A14L, is a structural protein of the vaccinia virus, which is a member of the Poxviridae family. This protein plays a crucial role in the assembly and maturation of the virus particles. It is involved in the formation of the virus's core, which is essential for the packaging of the viral genome. The A14 protein has been identified as a potential target for antiviral therapies due to its importance in the viral life cycle. It is highly conserved among different strains of the vaccinia virus, indicating its fundamental role in the virus's replication process. Research into the function and interaction of the A14 protein with other viral and host factors can provide valuable insights into the development of new antiviral strategies against poxviruses, including smallpox, which is a significant concern for global health security.
Shipping and Storage
This product is shipped at ambient temperature. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Liu, Liang, et al. "From crescent to mature virion: vaccinia virus assembly and maturation." Viruses 6.10 (2014): 3787-3808.